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ABSTRACT A plasmid construct expressing the p66 ver-
sion of the human immunodeficiency virus reverse transcrip-
tase as a bacterial fusion protein was subjected to in vitro
mutagenesis, and the resulting variant proteins were assayed to
derme the locations of the two major enzymatic activities. The
DNA polymerase activity was localized to the N-terminal
portion of the protein; mutations altering or eliminating the
C-terminal portion had little or no effect on that activity. The
results suggest that, in contrast with previous reports, the pSi
subunit found in virions should exhibit DNA polymerase
activity. Mutations in many parts of the protein eliminated
RNase H activity, suggesting that several areas are needed for
proper folding and generation of that activity.
The reverse transcriptase (RT) encoded by most mammalian
retroviruses is a monomeric protein of approximately 80 kDa
(reviewed in ref. 1). The enzyme is bifunctional: the single
polypeptide exhibits both a DNA polymerase activity that is
active on RNA or DNA templates and an associated RNase
H activity that is able to degrade RNA only in RNADNA
hybrid form (2-5). These two activities have been predicted
(6) and indeed demonstrated (7) to reside in separate do-
mains, with the DNA polymerase lying at the N terminus and
the RNase H at the C terminus. The RT of the human
immunodeficiency virus type 1 (HIV-1) (8, 9), the etiologic
agent of acquired immunodeficiency syndrome (AIDS), also
exhibits both enzymatic activities, and it has several distinc-
*tive biochemical properties in addition (10-12). The structure
of the HIV-1 RT is unusual in that the enzyme contains at
least two subunits: p66, exhibiting both DNA polymerase and
RNase H activity, and p51, reported as exhibiting neither
activity (13-16). Recently a third subunit, p15, has been
identified and described as having RNase H activity (16). The
structure of the subunits suggests that the enzyme is initially
formed as a homodimer of p66 subunits, and that one subunit
is cleaved to form the p51 and p15 molecules. The functional
consequences of the cleavage and the localization of activi-
ties to the resulting subunits remain unclear. Ultimately a
deeper understanding of the working ofthis enzyme is critical
to the development of specific and potent antiviral drugs to
block replication of the virus and to retard progression of the
associated immunodeficiency (17, 18).
We have previously constructed a plasm-id that expresses
the region corresponding to the p66 subunit of the HIV RT
encoded by the HXB2 provirus (19), as a trpE-RT fusion
protein (20, 21). The fusion protein is enzymatically active
and displays both the DNA polymerase and RNase H
activities found in the natural enzyme. To localize the two.
activities on the molecule and to define the regions critical for
these activities, we have now generated a library of mutations
in the expression plasmid and assayed the resulting mutant
proteins for their enzymatic functions.
MATERIALS AND METHODS
Construction of Linker Insertion Mutants. The parent
construct for all the manipulations was pHRTRX2, a plasmid
encoding a trpE-RT fusion with high stability and enzyme
activity (21). Enzymes (New England Biolabs) were used
according to the specifications of the manufacturer in stan-
dard protocols (22). The DNA was partially cleaved with one
of a selected set of restriction enzymes (Alu I, Rsa I, Dde I,
Hinfl, Nla IV, or Hae III), and the linear molecules resulting
from a single cut were purified by agarose gel electrophore-
sis. When necessary the ends were blunted by treatment with
the Klenow fragment ofDNA polymerase I, and oligonucle-
otide linkers containing the EcoRI cleavage site were ligated
to the termini. Linker sequences (5'-3') were GAATTC-
GAATTC and CGCGAATTCGCG. The DNAs were cleaved
with EcoRI, cyclized with T4 DNA ligase, and used to
transform Escherichia coli strain HB101 to ampicillin resis-
tance. DNA was isolated from various clones and screened
for the presence of an EcoRI cleavage site, and the position
of each insertion was determined by restriction mapping and
nucleotide sequencing. In some clones tandem copies of the
linker were found to be present.
Derivation of Additional Variant Plasmids from Linker
Insertion Mutants. Selected mutations were expanded by
cleavage with EcoRI, filling in the four-base recessed termini
with the Klenow fragment of DNA polymerase I, and
inserting a new 8-mer linker (GGAATTCC). Mutations de-
noted "TLI" were generated by cleavage of a selected linker
insertion mutant with EcoRI plus Xba I to remove the
C-terminal fragment, blunting with the Klenow fragment of
DNA polymerase I, and closure with insertion of an Xba I
terminator linker (CTAGTCTAGACTAG). Mutants denoted
"TL" contained a terminator codon generated by the original
EcoRI linker insertion, and those denoted "FS" contained a
gratuitous loss of bases at the site of insertion, forming a
frameshift mutation. Mutants AR1/R1 and R1/R1 30 were
formed by exchanging the matching EcoRI/JUpa I fragments
between the two mutants R6 and A2. Mutants denoted
"PDD" were formed by cleavage of the indicated insertion
mutant by BamHI plus EcoRI, filling in with Klenow frag-
ment, and closure with EcoRI linkers of the appropriate
length to conserve the reading frame.
Enzyme Assays. Growth of bacteria, induction of the trp
operon, lysis with lysozyme and detergent, and preparation
of extracts were all as described previously (23J. Determi-
Abbreviations: RT, reverse transcriptase; HIV, human immunode-
ficiency virus.
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nation of the levels of RNA-dependent DNA polymerase
activity, measured on the synthetic homopolymer substrate
oligo(dG)-poly(rC), were as before (20, 24), using 1 ,ul and 0.1
,ul of crude lysates for most assays. RNase H assays of
proteins after separation by SDS/polyacrylamide gel elec-
trophoresis (25) were similar to assays ofthe Moloney murine
leukemia virus enzyme (7), but incubations of the gel were in
buffer containing 5 mM MgCl2 rather than 2 mM MnCl2.
RESULTS
Construction of Mutants and Analysis of DNA Polymerase
Activity. As parent plasmid for mutagenesis, we selected
pHRTRX2 (21), encoding an extremely stable trpE-RT
fusion protein, 110 kDa in size and containing the complete
p66 region of the HIV RT. To introduce defined localized
alterations in the HIV RT molecule, we created a battery of
EcoRI linker insertion mutations at various positions along
the RT coding region. A total of21 distinct mutations with net
insertions ranging in length from 6 to 24 base pairs (bp) were
obtained and mapped; the amino acid changes generated by
each insertion are summarized in Table 1. To test the variants
for activity, cultures of E. coli containing each mutant
plasmid were starved for tryptophan to induce expression of
the fusion protein, and the cells were harvested and lysed.
Crude lysates were assayed for the stable accumulation ofthe
fusion protein by SDS/polyacrylamide gel electrophoresis
and for the level of RNA-dependent DNA polymerase activ-
ity as measured on homopolymer substrates [poly(rC) primed
with oligo(dG); ref. 24].
The results showed that most of the insertions mapping to
the N-terminal part ofthe protein abolished DNA polymerase
activity, while most mapping to the C-terminal part did not
(examples shown in Fig. 1; summarized in Fig. 2). These
results are similar to those obtained for the Moloney murine
leukemia virus RT (7), and they suggest that the DNA
polymerase function is similarly localized to the N-terminal
Table 1. Structure of insertion mutations in HIV RT
Mu- Restriction Net size of Amino acid changes
tant site* insertion, bp From To
Hal 2634 12 G G A N S R
Ha2 2653 12 WP WREFAP
Ha3 2734 24 GP GREFAREFAP
R3-6 2785 6 S T S E F T
R3-18 2785 18 S T SELEFQFT
R4 2904 6 V V N S
D2 2939 9 LD L E F L D
D3 3083 15 L LEFEFL
D4 3158 9 L E L E F L E
R6-6 3303 6 V V N S
R6-18 3303 18 V VNWNSNS
A2 3333 12 S R N S N S
D6-15 3429 15 L R L T R I R V R
D6-27 3429 27 LR LTRIGIPIRVR
A3 3481 12 E L EEFEFL
H2 3506 15 I L I E F E F I L
R7-6 3522 6 V V N S
R7-18 3522 18 V VNWNSNS
Ha4 3585 12 G G A N S R
H4 3812 9 I P I E F I P
R8 3860 12 Y SRIRD
N3 3859 24 Y S R I R A R I R D
A4 3917 12 A G I R I P
A5 4034 6 A G I P






































FIG. 1. RNA-dependent DNA polymerase assays of crude bac-
terial lysates from HIV RT mutant clones. Cultures were starved for
tryptophan to induce expression of the fusion proteins, and lysates
were prepared and assayed as described (21); autoradiographic
signals reflect labeled DNA synthesized on a synthetic RNA tem-
plate. For each extract, assays of 1 and 0.1 A1 are shown. Examples
of clones in three different separate experiments (A, B, and C) are
shown; the autoradiographic exposures were different for the sets,
but were the same for all samples within a given set. Examples with
wild-type activity and with various levels of lesser activity are
included. Control cultures with no plasmid (HB101) or with the
pATH2 vector alone demonstrate the low level of background
activity.
region. There were, however, several exceptional mutations.
First, two mutations near the C terminus significantly re-
duced polymerase activity; a similar mutation has been found
in the C terminus of the murine RT (7). Second, several
mutations in the N-terminal region, including an isolated one
(R3) and a cluster of insertions near the center of the protein,
were tolerated with little loss of activity (Fig. 2). Increasing
the size of two of these insertions from 6 to 18 bp (mutants
R3 and R6) did not affect the enzyme activity (Fig. 2),
although detailed analysis of these mutant proteins revealed
an increased thermolability relative to the parent (data not
shown). Thus, we suggest that these parts of the protein are
not critical for catalytic activity; perhaps they lie on the
surface of the protein, where insertion of additional sequence
is easily accommodated.
To confirm and extend these results, we generated a series
of deletion mutants from the linker insertion mutants (Fig. 2).
Analysis of these mutants showed that the C-terminal region
can be trimmed substantially without loss of polymerase
activity; specifically, constructs that include only the N-
terminal 50 kDa of the RT protein retained activity. These
results suggest that the pSi subunit of the natural RT contains
all the sequence information necessary for polymerase func-
tion and should be active. Deletions that intruded further into
the p51 region of the protein abolished polymerase activity.
Thus, as for the Moloney murine leukemia virus enzyme,
virtually all of the N-terminal region of the protein is
essential. Interestingly, a small duplication of sequence in the
central region was tolerated (mutant Ri/R1 30); this further
suggests that this position lies on the protein surface. Further
analysis showed that the observed activity did not result from
loss of the insert by homologous recombination.
Analysis of Mutant Proteins for RNase H Activity. All of the
mutants were also assayed for RNase H activity by using an
in situ gel electrophoresis assay (7, 25). Radiolabeled RNA in
*Map position based on nucleotide sequence of proviral DNA,
starting with first base pair at the left edge of the left long terminal
repeat defined as position 1.
Biochemistry: Prasad and Goff
3106 Biochemistry: Prasad and Goff
0 kb 0.5 kb 1 .0 kb 1 .5 kb
(12) (12) (24) (6) (9) (15) (9) (27)(12) (15) (18)
Hal Ha2 Ha3 R4 D2 D3 D4 D6 A3 H2 R7
m7~~~~~
R3 R6 A 2 D6 R7 Ha4 H4 R8 N3 A4 A5 N4
(6,18) (6,18) (12) (15) (6) (12) (9) (12) (24) (12) (6) (24)
l ~~~~.I,,,,, ,,,,,, ,,,,,_.
1hZ 25-1 00% 1 10-25% E 1-10% 0-1%
FIG. 2. Positions of linker insertion and deletion mutations and the effects of these mutations on DNA polymerase activity. The line at the
top represents the sequences of the HIV pol gene encoding the p66 RT (nucleotides 2583-4262 of clone HXB2, numbered from the left edge
of the left long terminal repeat); black boxes on the line indicate patches of close sequence similarity to the Moloney murine leukemia virus
RT [ref. 26 and our alignment (unpublished data)]. The position of each triangle indicates the site of a linker insertion mutation; the size of each
insertion (in bp) is indicated in parentheses. Lower lines indicate the structures of proteins encoded by various deletion mutants; boxed areas
represent retained sequences and thin lines represent missing sequences. The level of DNA polymerase activity demonstrated by each mutant


















FIG. 3. In situ gel assay for RNase H activity of HIV RT mutant clones. (Left) Coomassie blue-stained SDS/polyacrylamide gel of crude
extracts from mutant clones. Positions of molecular mass markers are given on the left in kDa. Each mutant expressed equal amounts of a stable
fusion protein of the same size as the wild-type protein, 110 kDa. (Right) Autoradiogram of an SDS/polyacrylamide gel demonstrating the
detection of RNase H activity. A gel was cast with 32P-labeled RNA in RNA-DNA hybrid form, and extracts were applied and run as in Left.
After incubation to permit renaturation of the protein and digestion of the substrate, the gel was fixed, dried, and exposed to x-ray film overnight.
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RNA*DNA hybrid form was uniformly distributed in the gel
matrix before the acrylamide was polymerized, extracted
proteins were applied and fractionated by electrophoresis,
and the enzyme was allowed to renature and digest the
substrate in the gel. Active species were identified by their
ability to form zones of clearing in the uniform label,
visualized by autoradiography (Fig. 3 Right). The results of
analysis of the linker insertion and deletion mutants permit
only tentative localization of the RNase H activity (Fig. 4).
Many insertions in the N-terminal RT region were tolerated,
and most insertions in the C terminus abolished RNase H
activity; the results are consistent with the idea that much of
the C terminus is important for RNase H function. But there
were many exceptional insertion mutations in the N terminus
which did affect RNase H, and others in the C terminus which
did not. Surprisingly, deletions affecting either the N or the
C terminus of the protein abolished activity, and only those
proteins with gross mutations that were restricted to the
center of the protein retained activity. In this assay the
protein is initially denatured and must renature to recover an
active site; thus, we can conclude that alterations in many
parts of the RT protein, at both N and C termini, affect the
efficient recovery of this activity. We should note that the
presence of the trpE sequences at the N terminus, although
profoundly stabilizing the DNA polymerase activity of the
fusion protein, might actually hinder the renaturation ofmany
potentially active mutant proteins.
0 kb 0.5kb
DISCUSSION
The analysis presented here suggests that the general orga-
nization of the HIV-1 RT is similar to that of other retroviral
RTs. In particular, the RNA-dependent DNA polymerase
function is localized to the N-terminal region as predicted (6)
and demonstrated (7) for the murine leukemia virus RT. Most
importantly, this analysis suggests that both the p51 and p66
subunits should have that activity. Previous failures to detect
activity in the p51 subunit (13-16) or in recombinant proteins
with deletions in the C terminus (27, 28) could be due to the
proteins' lability or inability to fold properly; the expression
ofthe protein as a fusion protein here might be responsible for
its stabilization. Recent results comparing the HIV RT
generated in bacteria without an N-terminal leader and
pHRTRX2 show that the presence of the trpE leader does
indeed increase profoundly the thermostability and ability to
renature of the DNA polymerase activity of the molecule (D.
Helland and W. A. Haseltine, personal communication). We
consider the alternative, that the trpE domain itself contrib-
utes DNA polymerase activity, to be unlikely. The results
here are supported by a very recent report that the p5i
protein does indeed exhibit at least some polymerase activity
(29), although our results show that appropriate C-terminal
mutations can exhibit wild-type levels ofthe polymerase. The
HIV RT in this analysis exhibited one noteworthy difference
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FIG. 4. Effects of linker insertion and deletion mutations on RNase H activity of HIV RT. The position and sizes of the various mutations
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insertions in the center of the HIV protein were well
tolerated, suggesting that the enzyme is more stable to such
alterations or contains a relatively nonessential region.
The RNase H domain could not be so simply localized, but
other reports suggest that it may be restricted to the C-
terminal part of the p66 and indeed localized in the p15
subunit (16). This work is fully consistent with that view. The
results, taken together, suggest that the HIV RT may be
formed as a p66 dimer, and that one of the two molecules is
normally cleaved to yield p51, a DNA polymerase, and p15,
an RNase H, thereby separating the two enzymatic activities.
The selective advantage to the virus for such cleavage, not
occurring in any other group of retroviruses, remains un-
known. Furthermore, the protease responsible remains un-
clear. Cleavage could be due to a variety of host proteases,
or breakage at this site could even be autocatalytic.
The constructs generated by our laboratory (20, 21) and
many others (27, 30-33) that permit the expression of active
HIV RT in microorganisms provide rapid access to large
quantities of protein. Batteries of characterized mutants,
including these and other types prepared by others (28, 34),
will be useful for a variety of studies. Coupled to more
detailed structural information, their analysis will facilitate
the identification of active sites and domains. In this regard
the localization ofa highly flexible region, in the middle of the
primary sequence of the DNA polymerase domain, is intrigu-
ing. The mutants may also be helpful as parents for the
isolation of second-site revertants, which could ultimately
identify intramolecular contacts in the folded protein.
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